Brief: EU agency backs Sanofi diabetes drug Toujeo plus medicines from Otsuka, Novartispproval in advanced non small cell lung cancer
27/02/2015 12:11
Feb 27 (Reuters) - European Medicines Agency: * EU medicines agency says recommends approval of new Sanofi SASY.PA diabetes drug Toujeo * EU medicines agency says Novartis NOVN.VX drug Zykadia recommended for approval in advanced non small cell lung cancer * EU medicines agency says recommends approval of Otsuka 4768.T kidney disease drug tolvaptan ((London Equities Newsroom; +44 20 7542 7717))